Article Sidebar

PDF
Date Published: 21/08/2021
Abstract Views: 625
Views PDF: 162
DOI: https://doi.org/10.51298/vmj.v504i2.947
Issue
Vol. 504 No. 2 (2021)
Section
Các bài báo
How to Cite
Trường Giang, N. ., & Văn Hưng, N. . (2021). EXPRESSION OF CYTOKERATIN 20 IN UROTHELIAL CARCINOMA OF BLADDER. Vietnam Medical Journal, 504(2). https://doi.org/10.51298/vmj.v504i2.947

EXPRESSION OF CYTOKERATIN 20 IN UROTHELIAL CARCINOMA OF BLADDER

Nguyễn Trường Giang1,, Nguyễn Văn Hưng2
1 Viet Tiep Hospital, Haiphong
2 Hanoi Medical University

Main Article Content

Abstract

Objectives To evaluate some features of CK 20 immunomarker and its relationship with histological grade, stage in surgical bladder tumor at Viet Duc hospital. Subjects and research methods: A retrospective study was perform in 99 cases of bladder carcinoma through surgical samples at Viet Duc hospital. Results: CK 20 marker was negative in 32 cases (32.3%), focal positive (<10% tumor cells) had 27 cases (27.3%), diffusely positive had 40 cases (40.4 %). CK 20 marker was related to histological grade with p=0.000<0.05 and related to disease stage with p=0.01<0.05. The relationships are statistically significant.

Article Details

Keywords

Urothelial carcinoma of bladder, cytokeratin 20

References

1. Nguyễn Phúc Cương, Nguyễn Sỹ Lánh, và Nguyễn Phương Hồng (2002), "Nghiên cứu hình ảnh giải phẫu bệnh của ung thư biểu mô đài bể thận," Báo cáo khoa học tại bệnh viện Việt Đức- Hà Nội.
2. Moch H, Humphrey PA, Ulbright TM et al (2016), "WHO classification of tumours of the urinary system and male genital organs. 4th Edition.World Health Organization," International Agency for Research on Cancer (IARC), vol. 8.
3. Lê Thanh Xuân (2020), "Đặc điểm mô bệnh học và sự bộc lộ các dấu ấn hoá mô miễn dịch CK20, P53, Ki67 trong ung thư biểu mô nhú đường niệu," luận văn thạc sỹ y học. đại học y hà nội.
4. Nguyễn Văn Hưng và Nguyễn Thị Hồng Điệp (2010), "Nghiên cứu mô bệnh học, một số triệu chứng lâm sàng và cận lâm sàng của ung thư biểu mô tiết niệu," Tạp chí Y học thực hành, vol. 4, p. 714.
5. Bertz S, Otto W, Denzinger S et al(2014), "Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer," European urology, vol. 65(1):, pp. 218-226.
6. Xiao X, Hu R, Deng F-M et al(2017), "Practical applications of immunohistochemistry in the diagnosis of genitourinary tumors. ," Archives of pathology & laboratory medicine., vol. 141(9), pp. 1181-1194.
7. Burger M, Denzinger S, Hartmann A et al (2007), "Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade.," British journal of cancer, vol. 96(11), pp. 1711-1715.
8. Mumtaz S, Hashmi AA, Hasan SH et al(2014), "Diagnostic utility of p53 and CK20 immunohistochemical expression grading urothelial malignancies," International archives of medicine, vol. 7(1), p. 36.
9. Yin H and Leong AS-Y(2004), "Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up.," American journal of clinical pathology, vol. 121(5), pp. 679-687.